Sofwave Medical Ltd. (IL:SOFW)
TASE:SOFW
SOFW Stock Chart & Stats
2800.00
-0.53(-3.47%)
At close: 4:00 PM EST
2800.00
-0.53(-3.47%)
Day’s Range― - ―
52-Week Range1,300.00 - 4,104.00
Previous CloseN/A
Volume25.73K
Average Volume (3M)26.78K
Market Cap
₪1.34B
Enterprise Value393.43M
Total Cash (Recent Filing)₪35.28M
Total Debt (Recent Filing)₪1.12M
Price to Earnings (P/E)51.4
Beta0.48
Next Earnings
May 13, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)37.00
Shares Outstanding36,111,660
10 Day Avg. Volume28,238
30 Day Avg. Volume26,779
Financial Highlights & Ratios
PEG Ratio-0.22
Price to Book (P/B)9.34
Price to Sales (P/S)3.22
P/FCF Ratio21.06
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Turnaround To ProfitabilitySofwave’s 2025 swing to operating profit and positive net income indicates the business model can scale to profitability once installed-base and utilization reach critical mass. This reduces reliance on external capital and supports longer-term investment in sales, training and product support if sustained.
Strong Cash GenerationMaterial positive operating and free cash flow provides durable financial flexibility: it funds working capital, service and marketing, and can finance unit placements or R&D without immediate dilution. Sustained cash generation materially improves resilience across business cycles.
Conservative Balance SheetLow leverage gives Sofwave durable optionality: ability to invest in commercialization, absorb short-term demand fluctuations, and pursue selective financing or partnerships from a position of strength, lowering insolvency risk and preserving strategic flexibility.
Bears Say
Historic Profitability VolatilityThe 2025 profit inflection follows several years of losses and negative operating cash flow, so the company’s earnings profile remains unproven across cycles. Reversion risk is meaningful if placements slow, pricing weakens, or consumable volumes decline, stressing the need for sustained execution.
Limited Margin TransparencyAbsent granular margin disclosure, it’s unclear whether 2025 profitability stems from sustainable pricing, improved gross margins, or one-off cost actions. That opacity complicates assessment of long-term operating leverage and the company’s ability to defend margins as competition or pricing pressure emerges.
Reliance On Installed-Base GrowthSofwave’s recurring revenue depends on new system placements and per-treatment consumable demand; this ties growth to commercial execution and distributor effectiveness. With a small employee base and concentrated go-to-market needs, scaling internationally and sustaining utilization could be operationally challenging.
Sofwave News
SOFW FAQ
What was Sofwave Medical Ltd.’s price range in the past 12 months?
Sofwave Medical Ltd. lowest stock price was 1300.00 and its highest was 4104.00 in the past 12 months.
What is Sofwave Medical Ltd.’s market cap?
Sofwave Medical Ltd.’s market cap is ₪1.34B.
When is Sofwave Medical Ltd.’s upcoming earnings report date?
Sofwave Medical Ltd.’s upcoming earnings report date is May 13, 2026 which is in 41 days.
How were Sofwave Medical Ltd.’s earnings last quarter?
Sofwave Medical Ltd. released its earnings results on Mar 17, 2026. The company reported 37 earnings per share for the quarter, beating the consensus estimate of N/A by 37.
Is Sofwave Medical Ltd. overvalued?
According to Wall Street analysts Sofwave Medical Ltd.’s price is currently Overvalued.
Does Sofwave Medical Ltd. pay dividends?
Sofwave Medical Ltd. does not currently pay dividends.
What is Sofwave Medical Ltd.’s EPS estimate?
Sofwave Medical Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sofwave Medical Ltd. have?
Sofwave Medical Ltd. has 36,111,660 shares outstanding.
What happened to Sofwave Medical Ltd.’s price movement after its last earnings report?
Sofwave Medical Ltd. reported an EPS of 37 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 7.016%.
Which hedge fund is a major shareholder of Sofwave Medical Ltd.?
Currently, no hedge funds are holding shares in IL:SOFW
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Sofwave Medical Ltd.
Sofwave Medical Ltd. develops an ultrasound technology for treating fine lines and wrinkles in Israel and internationally. It offers non-invasive skin treatment aesthetic medical devices to physicians. The company was incorporated in 2015 and is based in Yokne'am Illit, Israel.